BCL2 is constitutively overexpressed in CLL cells and confers resistance to apoptosis by binding to and disabling BCL2 homology domain 3 (BH3)-only proteins, which are instigators of the intrinsic cell death pathway[33,34]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.